Antipruritic Placebo Effects by Conditioning H1-antihistamine

Stefanie H Meeuwis, Henriët van Middendorp, Gustavo Pacheco-Lopez, Maarten K Ninaber, Adriana P M Lavrijsen, Nic van der Wee, Dieuwke S Veldhuijzen, Andrea W M Evers

Research output: Contribution to journalArticleScientificpeer-review

Abstract

OBJECTIVE: Allergic rhinitis symptoms can be reduced by behaviorally conditioning antihistamine. It is unclear whether these findings extend to histamine-induced itch or work when participants are informed about the conditioning procedure (open-label conditioning). The current study aims to investigate the efficacy of (open-label) antipruritic behavioral conditioning for histamine-induced itch.

METHODS: Healthy participants (n = 92; 84% female) were randomized to I) an open-label conditioned, II) closed-label conditioned, III) conditioned-not-evoked control, or IV) nonconditioned control group. A two-phase conditioning paradigm was used. During acquisition, a conditioned stimulus (CS; distinctively tasting beverage) was repeatedly paired with the H1-antihistamine levocetirizine (groups I-III). During evocation, the CS was paired with placebo (I, II), or instead of the CS, water was paired with placebo (III). The nonconditioned control group (IV) received CS with placebo in both phases. Itch after histamine iontophoresis and physiological data (i.e., spirometry, heart rate, skin conductance) were assessed. Combined conditioned and combined control groups were first compared, and analyses were repeated for separate groups.

RESULTS: Marginally lower itch was reported in the combined conditioned compared with the control groups (F(1,88) = 2.10, p = .076, ηpartial = 0.02); no differences between separate groups were found. No effects on physiological data were found, except for heart rate, which reduced significantly and consistently for control groups, and less consistently for conditioned groups (group by time interaction: F(7,80) = 2.35, p = .031, ηpartial = 0.17).

CONCLUSION: Limited support was found for the efficacy of antipruritic behavioral conditioning, regardless of whether participants were informed about the conditioning procedure. The application of open-label conditioning in patient populations should be further researched.

TRIAL REGISTRATION: www.trialregister.nl; ID NTR5544.

Original languageEnglish
Pages (from-to)841-850
Number of pages10
JournalPsychosomatic Medicine
Volume81
Issue number9
DOIs
Publication statusPublished - 2019
Externally publishedYes

Keywords

  • Adolescent
  • Adult
  • Cetirizine/pharmacology
  • Conditioning, Classical/physiology
  • Female
  • Histamine H1 Antagonists, Non-Sedating/pharmacology
  • Humans
  • Male
  • Placebo Effect
  • Pruritus/therapy
  • Young Adult

Fingerprint

Dive into the research topics of 'Antipruritic Placebo Effects by Conditioning H1-antihistamine'. Together they form a unique fingerprint.

Cite this